Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,427.34
(
-0.99%
)
US TECH 100
28,429.60
(
-1.26%
)
Dow Jones
49,657.43
(
-0.81%
)
Brent Oil
106.34
(
2.07%
)
Bitcoin
79,282.09
(
-2.19%
)
News Focus
News Focus
Post# of 257575
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: jq1234 post# 104861

Thursday, 09/23/2010 8:04:23 PM

Thursday, September 23, 2010 8:04:23 PM

Post# of 257575
NVS CEO Jimenez was on CNBC talking about Gilenya approval today. He emphasized the diversification advantage of NVS, espeically they are the second largest generic drug maker in the world.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today